المؤلفون: V. Gulyaev A., M. Khubutiya Sh., M. Novruzbekov S., A. Mironov S., O. Olisov D., K. Lutsyk N., S. Zhuravel V., K. Magomedov M., R. Akhmetshin B., B. Yaremin I., В. Гуляев А., М. Хубутия Ш., М. Новрузбеков С., А. Миронов С., О. Олисов Д., К. Луцык Н., С. Журавель В., К. Магомедов М., Р. Ахметшин Б., Б. Яремин И.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 11, № 1 (2019); 37-54 ; Трансплантология; Том 11, № 1 (2019); 37-54 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2019-11-1

مصطلحات موضوعية: xenotransplantation, history of medicine, genetic engineering, ксенотрансплантация, история медицины, генная инженерия

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/420/487; https://www.jtransplantologiya.ru/jour/article/view/420/496; Budiani-Saberi D.A., Delmonico F.L. Organ trafficking and transplant tourism: a commentary on the global realities. Am. J. Transpl. 2008;8(5):925–929. PMID: 18416734 DOI:10.1111/j.1600-6143.2008.02200.x; Ekser B., Ezzelarab M., Hara H., et al. Clinical xenotransplantation: the next medical revolution? Lancet. 2012;379(9816):672–683. PMID:2201902 DOI:10.1016/S0140-6736(11)61091-X; Yamada K., Scalea J. Current progress in xenogeneic tolerance. Curr. Opin. Organ Transplant. 2012;17(2):168–173. P M I D : 22262105 DOI :10.1097/MOT.0b013e32835090f6; Starzl T.E., Fung J., Tzakis A., et al. Baboon-to-human liver transplantation. Lancet. 1993;341(8837):65–71. PMID:8093402; Reemtsma K., Mccracken B.H., Schlegel J.U., et al. Renal Heterotransplantation in man. Ann. Surg. 1964;160:384–410. PMID:14206847; Cooper D.K.C., Ekser B., Tector A.J., et al. A brief history of clinical xenotransplantation. Int. J. Surg. 2015;23(Pt B):205–210. PMID:26118617 DOI:10.1016/j.ijsu.2015.06.060; Bailey L.L., Nehlsen-Cannarella S.L., Concepcion W., Jolley W.B. Baboon-tohuman cardiac xenotransplantation in a neonate. JAMA. 1985;254(23):3321–3329. PMID:2933538; Fink J.S., Schumacher J.M., Ellias S.L., et al. Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant. 2000;9(2):273–278. PMID:10811399; US Food and Drug Administration. United States. Availability for public disclosure and submission to FDA for public disclosure of certain data and information related to human gene therapy or xenotransplantation. Electron resource. Fed. Register. 2001;66(12):4688–4706. Available at: http://www.fda.gov/cber/rules/frgene011801.htm.; Gunzburg W.H. Xenotransplantation: A summary of the International business communications fourth international congress. Liver Transpl. Surg. 2000;6(3):388–394. PMID:10827248 DOI:10.1053/lv.2000.5067; Rood P.P., Tai H.C., Hara H., et al. Late onset of, development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants. Transplant. Int. 2007;20(12):1050–1058. PMID:17850234 DOI:10.1111/j.1432-2277.2007.00546.x; Platt J.L. A perspective on xenograft rejection and accommodation. Immunol. Rev. 1994;141:127–149. PMID:7868152; Lin C.C., Chen D., McVey J.H., et al. Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation. 2008;86(5):702–709. PMID:18791452 DOI:10.1097/TP.0b013e31818410a3; Yamada K., Scalea J. Current progress in xenogeneic tolerance. Curr. Opin. Organ Transplant. 2012;17(2):168–173. P M I D :22262105 DOI:10.1097/MOT.0b013e32835090f6; Gollackner B., Goh S.K., Qawi I., et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation. 2004;77(11):1735–1741. PMID:15201675; Cooper D.K., Good A.H., Koren E., et al. Identification of a-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl. Immunol. 1993;1(3):198– 205. PMID:7521740; Ramirez P., Montoya M.J., Rios A., et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant. Proc. 2005;37(9):4103–4106. PMID:16386637 DOI:10.1016/j.transproceed.2005.09.186; Ezzelarab M., Ayares D., Cooper D.K. The potential of genetically-modified pig mesenchymal stromal cells in xenotransplantation. Xenotransplantation. 2010;17(1):3–5. PMID:20149183 DOI:10.1111/j.1399-3089.2009.00567.x; Osborne F.N., Kalsi K.K., Lawson C., et al. Expression of human ecto-5'-nucleotidase in pig endothelium increases adenosine production and protects from NK cell-mediated lysis. Am. J. Transplant. 2005;5(6):1248–1255. PMID:15888028 DOI:10.1111/j.1600-6143.2005.00868.x; Хубутия М.Ш., Гуляев В.А., Хватов В.Б. и др. Иммунологическая толерантность при трансплантации органов. Трансплантология. 2017;9(3):211–225. DOI:10.23873/2074-0506-2017-9-3-211-225; Garkavenko O., Muzina M., Muzina Z., et al. Monitoring for potentially xenozoonotic viruses in New Zealand pigs. J. Med. Virol. 2004;72(2):338–344. PMID:14695679 DOI:10.1002/jmv.10575; Bittmann I., Mihica D., Plesker R., Denner J. Expression of porcine endogenous retroviruses (PERV) in different organs of a pig. Virology. 2012;433(2):329–36. PMID:22975674 DOI:10.1016/j.virol.2012.08.030; Zhao G., Moore D.J., Kim J.I., et al. An immunosufficient murine model for the study of human islets. Xenotransplantation. 2014;21(6):567–573. PMID:25041432 DOI:10.1111/xen.12126; Paradis K., Langford G., Long Z. et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissues. Science. 1999;285(5431):1236–1241. PMID:10455044; Chen G., Sun H., Yang H. et al. The role of anti-non-galantibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-gal antibody neutralization therapy. Transplantation. 2006;81(2):273–283. PMID:16436972 DOI:10.1097/01.tp.0000188138.53502.de; Cozzi E., Simioni P., Boldrin M., et al. Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation. Am. J. Transplant. 2004;4(3):335– 345. PMID:14961985; Denner J. The porcine virome and xenotransplantation. Virol. J. 2017; 14(1):171 . PMID:28874166 DOI:10.1186/s12985-017-0836-z; Güell M., Niu D., Kan Y., et al. PERV inactivation is necessary to guarantee absence of pig-to-patient PERVs transmission in xenotransplantation. Xenotransplantation. 2017;24(6). PMID:29171094 DOI:10.1111/xen.12366; Fischer K., Kraner-Scheiber S., Petersen B., et al. Efficient production of multi-modified pigs for xenotransplantation by 'combineering', gene stacking and gene editing. Sci. Rep. 2016;6:29081. PMID:27353424 DOI:10.1038/srep29081; Cooper D.K.C., Wijkstrom M., Hariharan S., et al. Selection of patients for initial clinical trials of solid organ xenotransplantation. Transplantation. 2017;101(7):1551–1558. PMID:27906824 DOI:10.1097/TP.0000000000001582; Chan J.L., Singh A.K., Corcoran P.C., et al. Encouraging experience using multi-transgenic xenografts in a pigto-baboon cardiac xenotransplantation model. Xenotransplantation. 2017;24(6). PMID:28940570 DOI:10.1111/xen.12330; Padela A.I., Duivenbode R. The ethics of organ donation, donation after circulatory determination of death, and xenotransplantation from an Islamic perspective. Xenotransplantation. 2018;25(3):1–12. PMID:29913041 DOI:10.1111/xen.12421; Tönjes R.R. Non-viral pathogens: Identification, relevance, and prevention for xenotransplantation. Xenotransplantation. 2018;25(3):e12413. PMID:29913046 DOI:10.1111/xen.12413; Cooper D.K., Pierson 3rd R.N., Hering B.J., et al. Regulation of clinical xenotransplantation – time for a reappraisal. Transplantation. 2017;101(8):1766–1769. PMID:28737658 DOI:10.1097/TP.0000000000001683; Hawthorne W.J., Cimeno A., Ezzelarab M., et al. Thomas Starzl – visionary and xenotransplantation pioneer: commentary from the International xenotransplant association vanguard committee. Xenotransplantation. 2017;24(2):e12310. PMID:28421679 DOI:10.1111/xen.12310; Pullen L.C. Xenotransplantation: time to get excited? Am. J. Transplant.2017;17(12):2995–2996. PMID:29145696 DOI:10.1111/ajt.14553; Paris W., Seidler R.J.H., FitzGerald K., et al. Jewish, Christian and Muslim theological perspectives about xenotransplantation. Xenotransplantation. 2018;25(3):e12400. PMID:29687920 DOI:10.1111/xen.12400; Llore N.P., Bruestle K.A., Griesemer A. Xenotransplantation tolerance: applications for recent advances in modified swine. Curr. Opin. Organ Transplant. 2018;23(6):642–648. PMID:30379724 DOI:10.1097/MOT.0000000000000585; Yamamoto T., Iwase H., King T.W., et al. Skin xenotransplantation: Historical review and clinical potential. Burns. 2018;44(7):1738–1749. PMID:29602717 DOI:10.1016/j.burns.2018.02.029; Platt J.L. Xenotransplantation: Biological Barriers. In: Encyclopedia of Animal Science. CRC Press, 2018. Vol. 2. 1117–1120.; Denner J. Can antiretroviral drugs be used to treat porcine endogenous retrovirus (PERV) infection after xenotransplantation? Viruses. 2017;9(8). pii:E213 PMID:28786944 DOI:10.3390/v9080213; https://www.jtransplantologiya.ru/jour/article/view/420

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/420
https://doi.org/10.23873/2074-0506-2019-11-1-37-54

المؤلفون: M. Khubutiya Sh., L. Zimina N., I. Galankina E., V. Gulyaev A., M. Novruzbekov S., O. Olisov D., K. Magomedov M., М. Хубутия Ш., Л. Зимина Н., И. Галанкина Е., В. Гуляев А., М. Новрузбеков С., О. Олисов Д., К. Магомедов М.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 10, № 2 (2018); 87-97 ; Трансплантология; Том 10, № 2 (2018); 87-97 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2018-10-2

مصطلحات موضوعية: standard donors, expanded criteria donors, histological evaluation of hepatic graft, steatosis, стандартные доноры, доноры с расширенными критериями оценки, гистологическая оценка печеночного трансплантата, стеатоз

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/223/278; https://www.jtransplantologiya.ru/jour/article/view/223/293; Feng S., Goodrich N.P., Bragg-Gresham J.L., et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am. J. Transplant. 2006;6(4):783–790. PMID:16539636 DOI:10.1111/j.1600-6143.2006.01242.x; Angelico M., Gridelli B., Strazzabosco M., A.I.S.F. Commission on Liver Transplantation. Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.). Dig. Liver Dis. 2005;37(7):461–467. PMID:15893508 DOI:10.1016/j.dld.2005.03.006; Campbell M.S., Kotlyar D.S., Brensinger C.M., et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl. 2005;11(9):1048–1055. PMID:16123966 DOI:10.1002/lt.20445; Day C.P., James O.F. Hepatic steatosis: innocent bystander or guilty party? Hepatology. 1998;27(6):1463– 1466. PMID:9620314 DOI:10.1002/hep.510270601; Галанкина И.Е., Зимина Л.Н. Патологоанатомические аспекты аллотрансплатации органов. В кн.: М.Ш. Хубутия (ред.). Трансплантация органов и тканей в многопрофильном научном центре. М.: Аир Арт., 2011. Гл. 13: 347–378.; Гуляев В.А. Повышение эффективности трансплантации печени путём совершенствования технологии изъятия и подготовки трансплантата. Дис. … д-ра мед.наук. М., 2016. 309 с.; Хубутия М.Ш., Гуляев В.А., Зимина Л.Н. и др. Комплексная оценка состояния печени после выполнения лапаротомии у мультиорганных доноров. Вестник трансплантологии и искусственных органов. 2012;(1):41–49.; Neil D.A., Hubsher S.G. Are parenchymal changes in early post-transplant biopsies related to preservationreperfusion injury or rejection? Biopsies related to preservation-reperfusion injury or rejection? Transplantation. 2001;71(11):1566–1572. PMID:11435966; Trevisani F., Colantoni A., Caraceni P., Van Thiel D.H. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J. Hepatol. 1996;24(1):114–121. PMID:8834034; Ludwig J., Gross J.B. Jr, Perkins J.D., Moore S.B. Persistent centrilobular necrosis in hepatic allografts. Hum. Pathol. 1990;21(6):656–661. PMID:2351393; Turlin B., Slapak G.I., Hayllar K.M., et al. Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients. Liver Transpl. Surg. 1995;1(5):285–289. PMID:9346584; Fromenty B., Pessayre D. Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines. J. Hepatol. 1997;26(Suppl. 2):43–53. PMID:9204409; Yoong K.F., Gunson B.K., Neil D.A., et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant. Proc. 1999;31(1– 2):550–551. PMID:10083232.; Bao Y.M., Adam R., Sebagh M., et al. Risk factors of preservation injury and prognostic value of reperfusion biopsy in outcome of liver transplantation. Transplant. Proc. 1996;28(1):123–125. PMID:8644141; Adam R., Reynes M., Johann M., et al. The outcome of steatotic grafts in liver transplantation. Transplant. Proc. 1991;23(1, Pt. 2):1538–1540. PMID:1989281; Tillery W., Demetris J., Watkins D., et al. Pathological recognition of preserv ation injury in hepatic allografts with six months follow-up. Transplant. Proc. 1989;21(1, Pt. 2):1330–1331. PMID:2652439; https://www.jtransplantologiya.ru/jour/article/view/223

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/223
https://doi.org/10.23873/2074-0506-2018-10-2-87-97

المؤلفون: A. Kurenkov V., M. Novruzbekov S., K. Magomedov M., S. Shvarts V., YU. Teterin S., A. Mironov V., O. Olisov D., А. Куренков В., М. Новрузбеков С., К. Магомедов М., С. Шварц В., Ю. Тетерин С., А. Миронов В., О. Олисов Д.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 10, № 1 (2018); 7-14 ; Трансплантология; Том 10, № 1 (2018); 7-14 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2018-10-1

مصطلحات موضوعية: orthotopic liver transplantation, biliary complications, anastomotic stricture, biliary anastomosis incompetence, biliary-duodenal stenting, endoscopic retrograde cholangiography, ортотопическая трансплантация печени, билиарные осложнения, анастомотическая стриктура, несостоятельность билиарных анастомозов, билиодуоденальное стентирование, эндоскопическая ретроградная холангиография

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/211/260; https://www.jtransplantologiya.ru/jour/article/view/211/270; Starzl T.E., Marchioro T.L., Vonkaulla K.N., et al. Homotransplantation of the liver in humans. Surg. Gynecol. Obstet. 1963;117:659–676. PMID:14100514; Calne R.Y. A new technique for biliary drainage in orthotopic liver transplantation utilizing the gall bladder as a pedicle graft conduit between the donor and recipient common bile duct. Ann. Surg. 1976;184(5):605–609. PMID:791164; Neuhaus P., Blumhardt G., Bechstein W.O., et al. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann. Surg. 1994;219(4):426–434. PMID:8161269; Fleck A., Zanotelli M.L., Meine M., et al. Billiary tract complication after orthotopic liver transplantation in adult patients. Transplantat. Proceed. 2002;34(2):519–520. DOI:10.1016/S0041-1345(02)02615-5; Grief F., Bronsther O.L., Van Thiel D.H., et al. The incidence, timing, and management of biliary tract complication after orthotopic liver transplantation. Ann. Surg. 1994;219(1):40–45. PMID:8297175; Qin Y.S., Li Z.S., Sun Z.X., et al. Endoscopic management of biliary complications after orthotopic liver transplantation. Hepatobiliary Pancreat. Dis. Int. 2006;5(1):39–42. PMID:16481280; Na G.H., Kim D.G., Choi H.J., et al. Interventional treatment of a biliary stricture after adult right-lobe living-donor liver transplantation with duct-to-duct anastomosis. HPB (Oxford). 2014;16:312–319. DOI:10.1111/hpb.12151; Олисов О.Д. Билиарные осложнения после ортотопической трансплантации печени. Трансплантология. 2009;(2): 44–50.; Alazmi W.M., Fogel E.L., Watkins J.L., et al. Recurrence of anastomotic biliary stricture in patients who have had previous successful endoscopic therapy for anastomotic narrowing after orthotopic liver transplant. Endoscopy. 2006;38(6):571–574. DOI:10.1055/s-2006-925027; Mocchegiani F., Vincenzi P., Lanari J., et al. Immunological risk factors in biliary strictures after liver transplantation. Ann. Transpl. 2015;20:218–224. DOI:10.12659/AOT.892393; Traina M., Tarantino I., Barresi L., et al. Efficacy and safety of fully covered self-expandable metallic stents in biliary complications after liver transplantation: a preliminary study. Liver Transpl. 2009;15(11):1493–1498. DOI:10.1002/ lt.21886.; Buis C.I., Hoekstra H., Verdonk R.C., Porte R.J. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J. Hepatobiliary Pancreat. Surg. 2006;13(6):517–524. DOI:10.1007/s00534-005-1080-2; Katsinelos P., Kountouras J., Paroutoglou G., et al. The role of endoscopic treatment in postoperative bile leaks. Hepatogastroenterology. 2006;53(68):166–170. PMID:16608016; Zhao Q., Chen Z.S., Qin H., et al. The role of endoscopic retrograde cholangiopancreatography in the diagnosis and therapy of biliary complications after orthotopic liver transplantation. Chin. J. Organ. Transplant. 2004;25(5):291–293. DOI:10.3760/cma.j.i ssn.0254-1785.2004.05.011; Thuluvath P.J., Pfau P.R., Kimmey M.B., Ginsberg GG. Biliary complications after liver transplantation: the role of endoscopy. Endoscopy. 2005;37(9):857– 863. DOI:10.1055/s-2005-870192; Morelli J., Mulcahy H.E., Willner I.R., et al. Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement. Gastrointest. Endosc. 2003;58(3):374–379. PMID:14528211; Morelli G., Fazel A., Judah J., et al. Rapid-sequence endoscopic management of posttransplant anastomotic biliary strictures. Gastrointest. Endosc. 2008;67(6):879–885. DOI:10.1016/j. gie.2007.08.046.; Гранов А.М., Гранов Д.А., Жеребцов Ф.К. и др. Трансплантация печени в РНЦРХТ. Опыт 100 операций. Вестник трансплантологии и искусственных органов. 2012;(4):11–16.; Thulavath P.J., Atassi T., Lee J. An endoscopic approach to biliary complications following orthotopic liver transplantation. Liver Int. 2003;23(3):156–162. PMID:12955878; Kahaleh M., Behm B., Clarke B.W., et al. Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? Gas-trointest. Endosc. 2008;67(3):446–454. DOI:10.1016/j.gie.2007.06.057.; Isayama H., Komatsu Y., Tsujino T., et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53(5):729–734. PMID:15082593; Shim C.S., Lee Y.H., Cho Y.D., et al. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy. 1998;30(4):345– 350. DOI:10.1055/s-2007-1001280; Ryu С.Н., Lee S.K. Biliary Strictures after Liver Transplantation. Gut Liver. 2011;5(2):133–142. DOI:10.5009/ gnl.2011.5.2.133.; https://www.jtransplantologiya.ru/jour/article/view/211

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/211
https://doi.org/10.23873/2074-0506-2018-10-1-7-14

المؤلفون: V. Gulyaev A., S. Zhuravel’ V., M. Novruzbekov S., O. Olisov D., K. Lutsyk n, M. Minina G., A. Mironov S., N. Kuznetsova K., K. Magomedov M., M. Khubutiya Sh, В. Гуляев А., С. Журавель В., М. Новрузбеков С., О. Олисов Д., К. Луцык Н., М. Минина Г., А. Миронов С., Н. Кузнецова К., К. Магомедов М., М. Хубутия Ш.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 10, № 4 (2018); 308-326 ; Трансплантология; Том 10, № 4 (2018); 308-326 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2018-10-4

مصطلحات موضوعية: machine perfusion, donor organs, liver transplantation, аппаратная перфузия, донорские органы, трансплантация печени

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/406/470; https://www.jtransplantologiya.ru/jour/article/view/406/480; Starzl T.E., Marchioro T.L., Vonkaulla K.N., et al. Homotransplantation of the liver in humans. Surg. Gynecol. Obstet. 1963;117:659–676. PMID:14100514; Wertheim J.A., Petrowsky H., Saab S., et al. Major challenges limiting liver transplantation in the United States. Am. J. Transplant. 2011;11(9):1773–1784. DOI:10.1111/j.1600-6143.2011.03587.x; Seal J.B., Bohorquez H., Reichman T., et al. Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donors. Liver Transpl. 2015;21(3):321–328. DOI:10.1002/lt.24071; Kim W.R., Lake J.R., Smith J.M., et al. Liver. Am. J. Transplant. 2016;16(Suppl 2):69–98. DOI.org/10.1111/ajt.13668; Goldaracena N., Barbas A.S., Selzner M. Normothermic and subnormothermic ex-vivo liver perfusion in liver transplantation. Curr. Opin. Organ. Transplant. 2016;21(3):315–321. DOI:10.1097/MOT.0000000000000305; Singhal A., Wima K., Hoehn R.S., et al. Hospital resource use with donation after cardiac death allografts in liver transplantation: a matched controlled analysis from 2007 to 2011. J. Am. Coll. Surg. 2015;220(5):951–958. DOI:10.1016/j.jam-collsurg.2015.01.052; Deshpande R., Heaton N. Can nonheart-beating donors replace cadaveric heart-beating liver donors. J. Hepatol. 2006;45(4):499–503. DOI:10.1016/j.jhep.2006.07.018; de Vera M.E., Lopez-Solis R., Dvorchik I., et al. Liver transplantation using donation after cardiac death donors: Longterm follow-up from a single center. Am. J. Transplant. 2009; 9(4):773–781. DOI:10.1111/j.1600-6143.2009.02560.x; Abt P.L., Desai N.M., Crawford M.D., et al. Survival following liver transplantation from non-heart-beating donors. Ann. Surg. 2004;239(1):87–92. DOI:10.1097/01.sla.0000103063.82181.2c; Dutkowski P., Schlegel A., Slankamenac K., et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann. Surg. 2012;256(5):861–868. DOI:10.1097/SLA.0b013e318272dea2; Nemes B., Gámán G., Polak W.G. et al. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. Expert. Rev. Gastroenterol. Hepatol. 2016; 10(7): 841–859. DOI: 10.1 586/17474124.2016.1149062; Drobnis E.Z., Crowe L.M., Berger T., et al. Cold shock damage is due to lipid phase transitions in cell membranes: a demonstration using sperm as a model. J. Exp. Zool. 1993;265(4):432–437. DOI:10.1002/jez.1402650413; Chernyak B.V., Izyumov D.S., Lyamzaev K.G., et al. Production of reactive oxygen species in mitochondria of HeLa cells under oxidative stress. Biochim. Biophys. Acta. 2006;1757(5–6):525– 534. DOI:10.1016/j.bbabio.2006.02.019; van Golen R.F., van Gulik T.M., Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/ reperfusion injury. Free Radic. Biol. Med. 2012;52(8):1382–1402. DOI:10.1016/j.freeradbiomed.2012.01.013; Zhai Y., Petrowsky H., Hong J.C., et al. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 2013;10(2):79–89. DOI:10.1038/nrgastro.2012.225; Loor G., Kondapalli J., Iwase H., et al. Mitochondrial oxidant stress triggers cell death in simulated ischemiareperfusion. Biochim. Biophys. Acta. 2011;1813(7):1382–1394. DOI:10.1016/j.bbamcr.2010.12.008; Schlegel A., Graf R., Clavien P.A., Dutkowski P. Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation. J. Hepatol. 2013;59(5):984–991. DOI:10.1016/j. jhep.2013.06.022; Furukawa H., Todo S., Imventarza O., et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation. 1991;51(5):1000–1004. PMID:2031256; Vilca Melendez H., Rela M., Murphy G., Heaton N. Assessment of graft function before liver transplantation: quest for the lost ark? Transplantation. 2000;70(4):560–565. PMID:10972207; Carrel A., Lindbergh C.A. The culture of whole organs. Science. 1935;81:621– 623. DOI:10.1126/science.81.2112.621; Marchioro T.L., Huntley R.T., Waddell W.R., Starzl T.E. Extracorporeal perfusion for obtaining postmortem homografts. Surgery. 1963;54:900–911. PMID:14087127; Kestens P.J., Mikaeloff P., Haxhe J.J., et al. Homotransplantation of the canine liver after hypothermic perfusion of long duration. Bull. Soc. Int. Chir. 1966;25(6):647–659. PMID:4861669; Slapak M., Wigmore R.A., MacLean L.D. Twenty-four hour liver preservation by the use of continuous pulsatile perfusion and hyperbaric oxygen. Transplantation. 1967;5(4, Suppl.):1154–1158. PMID:4860607; Brettschneider L., Groth C.G., Starzl T.E. Experimental and clinical preservation of orthotopic liver homografts. In: Norman J. (ed.) Organ perfusion and preservation. New York: Appleton-Century Crofts, 1968: 271–284.; Menasche P., Termignon J.L., Pradier F., et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur. J. Cardiothorac. Surg. 1994;8(4):207– 2013. PMID:8031565; Stone J.P., Sevenoaks H., Sjoberg T., et al. Mechanical removal of dendritic cell-generating non-classical monocytes via ex vivo lung perfusion. J. Heart. Lung. Transplant. 2014;33(8):864–869. DOI:10.1016/j.healun.2014.03.005; Karangwa S. A., Dutkowski P., Fontes P., et al. Machine Perfusion of Donor Livers for Transplantation: A Proposal for Standardized Nomenclature and Reporting Guidelines. Am. J. Transplant. 2016;16(10):2932–2942. DOI:10.1111/ajt.13843; Belzer F.O., Glass N.R., Sollinger H.W., et al. A new perfusate for kidney preservation. Transplantation. 1982;33(3):322– 323. PMID:7039039; Lee M.P., Gear A.R. The effect of temperature on mitochondrial membrane-linked reactions. J. Biol. Chem. 1974;249(23):7541–7549. PMID:4279918; Reeb J., Keshavjee S., Cypel M. Expanding the lung donor pool: advancements and emerging pathways. Curr. Opin. Organ. Transplant. 2015;20(5):498–505. DOI:10.1097/MOT.0000000000000233; St. Peter S.D., Imber C.J., Friend P.J. Liver and kidney preservation by perfusion. Lancet. 2002;359:604–613. DOI:10.1016/S0140-6736(02)07749-8; Chatauret N., Coudroy R., Delpech P.O., et al. Mechanistic analysis of nonoxygenated hypothermic machine perfusion's protection on warm ischemic kidney uncovers greater eNOS phosphorylation and vasodilation. Am. J. Transplant. 2014;14(11):2500–2514. DOI:10.1111/ajt.12904; van der Plaats A., 't Hart N.A., Verkerke G.J., et al. Hypothermic machine perfusion in liver transplantation revisited: Concepts and criteria in the new millenium. Ann. Biomed. Eng. 2004;32(4):623–631. PMID:15117035; Dutkowski P., Schlegel A., de Oliveira M., et al. HOPE for human liver grafts obtained from donors after cardiac death. J. Hepatol. 2014; 60(4):765–772. DOI:10.1016/j.jhep.2013.11.023; Changani K.K., Fuller B.J., Bryant D.J., et al. Non-invasive assessment of ATP regeneration potential of the preserved donor liver. A 31P MRS study in pig liver. J. Hepatol. 1997;26(2):336–342. PMID:9059955; Jomaa A., Gurusamy K., Siriwardana P.N., et al. Does hypothermic machine perfusion of human donor livers affect risks of sinusoidal endothelial injury and microbial infection? A feasibility study assessing flow parameters, sterility, and sinusoidal endothelial ultrastructure. Transplant. Proc. 2013;45(5):1677–1683. DOI:10.1016/j.transproceed.2013.01.011; Hart N.A., der van Plaats A., Leuvenink H.G., et al. Determination of an adequate perfusion pressure for continuous dual vessel hypothermic machine perfusion of the rat liver. Transpl. Int. 2007;20(4):343–352. DOI:10.1111/j.1432-2277.2006.00433.x; Fondevila C., Hessheimer A.J., Maathuis M.H., et al. Hypothermic oxygenated machine perfusion in porcine donation after circulatory determination of death liver transplant. Transplantation. 2012;94(1):22–29. DOI:10.1097/TP.0b013e31825774d7; Minor T., Manekeller S., Sioutis M., Dombrowski F. Endoplasmic and vascular surface activation during organ preservation: Refining upon the benefits of machine perfusion. Am. J. Transplant. 2006;6(6):1355–1366. DOI:10.1111/j.1600-6143.2006.01338.x; Pienaar B.H., Lindell S.L., van Gulik T., et al. Seventy-two-hour preservation of the canine liver by machine perfusion. Transplantation. 1990;49(2):258–260. PMID:2305453; Guarrera J.V., Henry S.D., Samstein B., et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am. J. Transplant. 2010;10(2):372–381. DOI:10.1111/j.1600-6143.2009.02932.x; Schlegel A., Dutkowski P. Role of hypothermic machine perfusion in liver transplantation. Transpl. Int. 2015;28(6):677–689. DOI:10.1111/tri.12354; Tang D., Kang R., Zeh H.J. 3rd, Lotze M.T. High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox. Signal. 2011;14(7):1315–1335. DOI:10.1089/ars.2010.3356; Schlegel A., de Rougemont O., Graf R., et al. Protective mechanisms of endischemic cold machine perfusion in DCD liver grafts. J. Hepatol. 2013;58(2):278– 286. DOI:10.1016/j.jhep.2012.10.004; Howard T.K., Klintmalm G.B., Cofer J.B., et al. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation. 1990;49(1):103–107. PMID:2300999; Liu Q., Nassar A., Farias K., et al. Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl. 2014;20(8);987–999. DOI:10.1002/lt.23906; Dutkowski P., Schönfeld S., Heinrich T., et al. Reduced oxidative stress during acellular reperfusion of the rat liver after hypothermic oscillating perfusion. Transplantation. 1999;68(1):44–50. PMID:10428265; Dutkowski P., Graf R., Clavien P.A. Rescue of the cold preserved rat liver by hypothermic oxygenated machine perfusion. Am. J. Transplant. 2006;6(5 Pt1):903–912. DOI:10.1111/j.16006143.2006.01264.x; Bruinsma B.G., Berendsen T.A., Izamis M., et al. Determination and extension of the limits to static cold storage using subnormothermic machine perfusion. Int. J. Artif. Organs. 2013;36(11):775–780. DOI:10.5301/ijao.5000250; Guarrera J.V., Henry S.D., Samstein B., et al. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am. J. Transplant. 2015;15(1):161– 169. DOI:10.1111/ajt.12958; Upadhya G.A., Topp S.A., Hotchkiss R.S., et al. Effect of cold preservation on intracellular calcium concentration and calpain activity in rat sinusoidal endothelial cells. Hepatology. 2003;37(2):313–323. DOI:10.1053/jhep.2003.50069; Schlegel A., Kron P., Dutkowski P. Hypothermic oxygenated liver perfusion: basic mechanisms and clinical application. Curr. Transplant. Rep. 2015;2(1):52– 62.; Dutkowski P., Polak W.G., Muiesan P., et al. First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis. Ann. Surg. 2015;262(5):764–770. DOI:10.1097/SLA.0000000000001473; Sutton M.E., Op den Dries S., Karimian N., et al. Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS ONE. 2014;9(11):e110642. DOI:10.1371/journal.pone.0110642; Minor T., Efferz P., Fox M., et al. Controlled oxygenated rewarming of cold stored liver grafts by thermally graduated machine perfusion prior to reperfusion. Am. J. Transplant. 2013;13(6):1450– 1460. DOI:10.1111/ajt.12235; Bruinsma B.C., Yeh H., Ozer S., et al. Subnormothermic Machine Perfusion for Ex Vivo Preservation and Recovery of the Human Liver for Transplantation. Am. J. Transpl. 2014;14(6):1400–1409. DOI:10.1111/ajt.12727; Lüer B., Koetting M., Efferz P., Minor T. Role of oxygen during hypothermic machine perfusion preservation of the liver. Transpl. Int. 2010;23(9):944–950. DOI:10.1111/j.1432-2277.2010.01067.x; Manekeller S., Schuppius A., Stegemann J., et al. Role of perfusion medium, oxygen and rheology for endoplasmic reticulum stress-induced cell death after hypothermic machine preservation of the liver. Transpl. Int. 2008;21(2):169–177. DOI:10.1111/j.1432-2277.2007.00595.x; Perk S., Izamis M.L., Tolboom H., et al. A metabolic index of ischemic injury for perfusion-recovery of cadaveric rat livers. PLoS ONE. 2011;6(12):e28518. DOI:10.1371/journal.pone.0028518; Hohenester S., Wenniger L.M., Paulusma C.C., et al. A biliary HCO3– umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology. 2012;55(1):173–183. DOI:10.1002/hep.24691; Berendsen T.A., Bruinsma B.G., Lee J., et al. A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation. Transplant. Res. 2012;1(1):6. DOI:10.1186/2047-1440-1-6; Perk S., Izamis M.L., Tolboom H., et al. A fitness index for transplantation of machine-perfused cadaveric rat livers. BMC Res. Notes. 2012;5:325.; Schlegel A., Kron P., Graf R., et al. Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. Ann. Surg. 2014;260(5):931– 937. DOI:10.1097/SLA.0000000000000941; Spetzler V.N., Goldaracena N., Echiverri J., et al. Subnormothermic ex vivo liver perfusion is a safe alternative to cold static storage for preserving standard criteria grafts. Liver Transpl. 2016;22(1):111–119. DOI:10.1002/lt.24340; Op den Dries S., Karimian N., Sutton M.E., et al. Ex vivo normothermic machine perfusion and viability testing of discarded human donor livers. Am. J. Transplant. 2013;13(5):1327–1335. DOI:10.1111/ajt.12187; Fondevila C., Hessheimer A.J, Ruiz A., et al. Liver transplant using donors after unexpected cardia death: novel preservation protocol and acceptance criteria. Am. J. Transplant. 2007;7(7):1849–1855. DOI:10.1111/j.1600-6143.2007.01846.x; Хубутия М.Ш., Гуляев В.А., Хватов В.Б. и др. Иммунологическая толерантность при трансплантации органов. Трансплантология. 2017;9(3):211–225. DOI:10.23873/2074-0506-2017-9-3-211225; Watson C.J., Kosmoliaptsis V., Randle L.V., et al. Preimplantnormothermic liver perfusion of a suboptimal liver donated after circulatory death. Am. J. Transplant. 2016;16(1):353–357. DOI:10.1111/ajt.13448; Perera T., Mergental H., Stephenson B., et al. First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion. Liver Transpl. 2016;22(1):120–124. DOI:10.1002/lt.24369; Nagrath D., Xu H., Tanimura Y., et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab. Eng. 2009; 11(4–5):274–283. DOI:10.1016/j.ymben.2009.05.005; Jamieson R.W., Zilvetti M., Roy D., et al. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation. 2011;92(3):289–295. DOI:10.1097/TP.0b013e318223d817; Nakajima D., Cypel M., Bonato R., et al. Ex vivo perfusion treatment of infection in human donor lungs. Am. J. Transplant. 2016;16(4):1229–1237. DOI:10.1111/ajt.13562; Brockmann J., Reddy S., Coussios C., et al. Normothermic perfusion: A new paradigm for organ preservation. Ann. Surg. 2009;250(1):1–6. DOI:10.1097/SLA.0b013e3181a63c10; St. Peter S.D., Imber C.J., Kay J., et al. Hepatic control of perfusate homeostasis during normothermicextrocorporeal preservation. Transplant. Proc. 2003;35(4):1587–1590. PMID:12826227; Ravikumar R., Leuvenink H., Friend P.J. Normothermic liver preservation: a new paradigm? Transpl. Int. 2015;28(6):690–699. DOI:10.1111/tri.12576; Laing R.W., Mergental H., Mirza D.F. Normothermic ex-situ liver preservation: the new gold standard. Curr. Opin. Organ. Transplant. 2017;22(3):274–280. DOI:10.1097/MOT.0000000000000414; Shapey I.M., Muiesan P. Regional perfusion by extracorporeal membrane oxygenation of abdominal organs from donors after circulatory death: A systematic review. Liver Transpl. 2013;19(12):1292–1303. DOI:10.1002/lt.23771; Sanchez-Fructuoso A.I., Marques M., Prats D., et al. Victims of cardiac arrest occurring outside the hospital: A source of transplantable kidneys. Ann. Intern. Med. 2006;145(3):157–164. PMID:16880457; Минина М.Г., Хубутия М.Ш., Губарев К.К. и др. Практическое использование экстракорпоральной мембранной оксигенации в донорстве органов при трансплантации. Вестник трансплантации и искусственных органов. 2012;14(1):27–35. DOI:10.15825/1995-1191-2012-1-27-35; He X., Ji F., Zhiheng Zh., et al. Combined liver-kidney perfusion enhances protective effects of normothermic perfusion on liver grafts from donation after cardiac death. Liver Transpl. 2018;24(1):67–79. DOI:10.1002/lt.24954; Banan B., Watson R., Xu M. Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers. Liver Transpl. 2016;22(7):979–993. DOI:10.1002/lt.24451; Op den Dries S. Bile duct injury in liver transplantation: studies on etiology and the protective role of machine perfusion: dissertation. Groningen, the Netherlands: University of Groningen; 2013. 253p.; Trakarnsanga K., Griffiths R.E., Wilson M.C., et al. An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells. Nat Commun. 2017;8(7):14750. DOI:10.1038/ncomms14750; Гуляев В.А. Повышение эффективности трансплантации печени путём совершенствования технологии изъятия и подготовки трансплантата. Дис. … д-ра мед. наук. М., 2016. 299 с.; Sakota D., Sakamoto R., Sobajima H., et al. Mechanical damage of red blood cells by rotary blood pumps: selective destruction of aged red blood cells and subhemolytic trauma. Artif. Organs. 2008;32(10):785–791. DOI:10.1111/j.1525-1594.2008.00631.x; Fontes P., Lopez R., van der Plaats A., et al. Liver preservation with machine perfusion and a newly developed cell free oxygen carrier solution under subnormothermic conditions. Am. J. Transplant. 2015;15(2):381–394. DOI:10.1111/ajt.12991; Rauen U., Petrat F., Li T., De Groot H.H. Hypothermia injury/cold induced apoptosis–evidence of an increase in chelatable iron causing oxidative injury in spite of low O –/ H O formation. FASEB J. 2000;14(13):1953–1964. DOI:10.1096/fj.00-0071com; Selzner M., Goldaracena N., Echeverri J., et al. Normothermic ex vivo liver perfusion using Steen solution as perfusate for human liver transplantation-first North American results. Liver Transpl. 2016;22(11):1501–1508. DOI:10.1002/ lt.24499; Niemann C.U., Feiner J., Swain S., et al. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N. Engl. J. Med. 2015;373(27):405– 414. DOI:10.1056/NEJMc1511744; Barbas A.S., Knechtle S.J. Expanding the Donor Pool With NormothermicEx Vivo Liver Perfusion: The Future Is Now Am. J. Transplant. 2016;16(11):3075– 3076. DOI:10.1111/ajt.13959; Ravikumar R., Jassem W., Mergental H., et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am. J. Transplant. 2016;16(6):1779– 1787. DOI:10.1111/ajt.13708; Graham J.A., Guarrera J.V. “Resuscitation” of marginal liver allografts for transplantation with machine perfusion technology. J. Hepatol. 2014;61(2):418– 431. DOI:10.1016/j.jhep.2014.04.019; Mergental H., Perera T., Laing R.W., et al. Transplantation of Declined Liver Allografts Following Normothermic Ex-Situ Evaluation. Am. J. Transplant. 2016;16(11):3235–3245. DOI:10.1111/ajt.13875; Quillin R.C., Guarrera J.V. “In 10 years” of debate: Pro–machine perfusion for liver preservation will be universal. Liver Transpl. 2016;22(Suppl 1):S25–S28. DOI:10.1002/lt.24630; https://www.jtransplantologiya.ru/jour/article/view/406

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/406
https://doi.org/10.23873/2074-0506-2018-10-4-308-326